Utility of alendronate in metabolic bone diseases after gastrectomy

Japanese Journal of Gastroenterological Surgery

Volumn 44, Issue 4, 2011, Pages 361-373

  Sugiyama, Mitsugi ^a   Kunisaki, Chikara ^b   Kato, Hiroyuki ^c   Imada, Toshio ^d   Shimada, Hideaki ^e   Hirata, Koichi ^f   Kosaka, Takeo ^g   Yoshida, Masashi ^h   Kitajima, Masaki ^h   Aiko, Takashi ⁱ  

^a Yokohama City University Medical Center ^*  (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^e TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^f SAPPORO MEDICAL UNIVERSITY   (Japan)

^g KANAZAWA MEDICAL UNIVERSITY   (Japan)

^h International University of Health and Welfare Mita Hospital   (Japan)

ⁱ KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Alendronate; Bone turnover markers; Lumbar bone mineral density; Metabolic bone diseases after gastrectomy

Indexed keywords

EID: 79955777592     PISSN: 03869768     EISSN: 13489372     Source Type: Journal    
DOI: 10.5833/jjgs.44.361     Document Type: Article

References (16)

1. Japanese Source 1995;14:509-11.
2. Japanese Source1989;31:1178-85.
3. Adachi JD. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial. Arthritis & Rheumatism 2001;44:202-11.
4. American Gastroenterological Association. American Gastroenterological Association Medical Position Statement: Guidelines on Osteoporosis in gastrointestinal diseases. Gastroenterology 2003;124:791-4.
5. Bernstein CN, et al. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 2003;124:795-841.
6. Japanese Source 2000 Japanese Source 2001;18:76-82.
7. Japanese Source1996 Japanese Source 1997;14:219-33.
8. Zittel TT, Zeeb B, Maier GW, et al. High prevalence of bone disorders after gastrectomy. Am J Surg 1997;174:431-8.
9. Heiskanen JT, Kroger H, Paakkonen M, et al. Bone mineral metabolism after total gastrectomy. Bone 2001;28:123-7.
10. Inoue K, Shiomi K, Higashide S, et al. Metabolic bone disease following gastrectomy: assessment by dual energy X-ray absorptiometry. Br J Surg 1992;79:321-4.
11. Sahota O, Mundey MK, San P, et al. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 2004;35: 312-9.
12. Davis M, Heys SE, Selby PL, et al. Increased catabolism of 25-hydoro-xyvitamin D in patients with partial gastrectomy and elevated 1,25-dihy-doroxyvitamin D levels. Implications for metabolic bone disease. J Clin Endo- crinol- Metab 1997;82:209-12.
13. Japanese Source D Japanese Source D Japanese Source 2007;96:742-7.
14. Pasco JA, Henry MJ, Kotowicz MA, et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 2004;19:752-8.
15. Japanese Source Op Japan 2005;13:332-6.
16. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: A meta-analysis. JAMA 2004; 291:1999-2006.